News

News and Press Releases
About the CF Foundation | Public Policy | Clinical Trials The Cystic Fibrosis Foundation Celebrates Passage of the Ensuring Access to Clinical Trials Act of 2015

CFF-Championed Bill Eliminates Barriers to Participation in Clinical Trials for People with CF and other Rare Diseases

| 5 min read
About the CF Foundation | Public Policy | Clinical Trials Cystic Fibrosis Foundation Provides Expert Testimony to Congress in Support of the Ensuring Access to Clinical Trials Act

Bill Would Remove Barrier to Clinical Research for Rare Diseases by Ensuring that Clinical Trial Participants Don't Lose Critical Health Benefits

| 3 min read
About the CF Foundation Cystic Fibrosis Foundation Announces Leadership Transition

Robert J. Beall, Ph.D., today announced he will step down as president and chief executive officer of the Cystic Fibrosis Foundation, effective December 31, 2015. Preston W. Campbell III, M.D., currently the Foundation's executive vice president for medical affairs, will succeed Dr. Beall as president and CEO.

| 6 min read
About the CF Foundation | CFTR Modulators CF Foundation Celebrates FDA Approval of Orkambi as Important Advance for the CF Community

Drug Targets the Underlying Cause of the Disease in People with the Most Common CF Mutation

| 5 min read
About the CF Foundation | Cystic Fibrosis Foundation Therapeutics (CFFT) | Research Cystic Fibrosis Foundation Therapeutics Announces $14 Million Research Expansion with Genzyme

Program Aimed at Advancing Search for Therapies Targeting Most Common Mutation of CF

| 3 min read